growth
2/2 Seats Evidenced
Strongest: None · Weakest: None
No unresolved factor question.
Core Model Evidence Audit
Current Core Model
Evidence Audit
Current for Research AuditResearch evidence only. Model membership and weights require independent human review.
live-core-horizons-63d-126d6 Funded Seats63d126d
Evidence Audit Servicegen 2026-07-19 8:13 AM PDTas of 2026-07-19 8:13 AM PDT1804 Current Rows
- Maintained Lane
- core_folds_v2_comparability
- Evidence Run
- 1947f9d825523d46
- Feature World
- comparability_statement_inferred_v2
- Matches Live
- Identity Hashes
- Current
- model 7bf54f7f4419 · scoring 660048412d34 · rank 70d8e960ad77
- Apply Receipt
- Unknown
Funded Seats
Every Live Signal, Including Missing Evidence
| Factor | Signal | Weight | IC | t-stat | Coverage | Closest Peer | Assessment | Confidence |
|---|---|---|---|---|---|---|---|---|
| quality | asset_turnover_chg_4q | 18% | 0.069 | 2.2 | 98% | quality_delta_anchor_v150% overlap | adequatecurrent comparable evidencecurrent comparable evidence | medium |
| quality | deleveraging_growth_value_blend_v1 | 9% | 0.066 | 1.8 | 83% | fcf_growth_50p_gate_accel_x_value_v263% overlap | adequatecurrent comparable evidencecurrent comparable evidence | medium |
| growth | growth_peer_soft_gate_accel_x_value_2606_de1fc341 | 11% | 0.054 | 1.5 | 93% | quality_peer_roic_momentum_x_accruals_2606_e324055f33% overlap | adequatecurrent comparable evidencecurrent comparable evidence | medium |
| quality | quality_delta_anchor_v1 | 9% | 0.066 | 2.2 | 98% | assetTurnover50% overlap | adequatecurrent comparable evidencecurrent comparable evidence | medium |
| growth | rev_growth_value_quality_blend_v1 | 24% | 0.094 | 2.3 | 94% | fcf_growth_50p_gate_accel_x_value_v243% overlap | adequatecurrent comparable evidencecurrent comparable evidence | medium |
| valuation | valuation_peer_ps_metric_state_blend_70_30_2606_6c11b8c0 | 29% | 0.034 | 0.7 | 96% | valuation_peer_ps_state_anchor_blend_2606_d35c28bc40% overlap | adequatecurrent comparable evidencecurrent comparable evidence | medium |
Factor Audit
Allocation & Evidence Gaps
complete · 35%
quality
3/3 Seats Evidenced
Strongest: None · Weakest: None
No unresolved factor question.
valuation
1/1 Seats Evidenced
Strongest: None · Weakest: None
No unresolved factor question.
Research Priority
Highest-Value Next Proofs
- 1
Review reused substrate: priceSalesRatio
mediumUsed by 4 funded seats covering 73% weight
Next Proof: Inspect the underlying rows and write a human research note on whether the shared substrate is economically redundant.
Open Frontier
Candidate Leads
No unresolved candidate leads in the bounded audit.
Decision Memory
Recent Relevant Outcomes
No relevant durable decisions found.